Zometa side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Zometa. Common side effects include osteonecrosis among females, and death among males.
The phase IV clinical study is created by eHealthMe based on 69,895 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
69,895 people who take Zometa and have side effects are studied.
What is Zometa?
Zometa has active ingredients of zoledronic acid. It is used in multiple myeloma. Currently, eHealthMe is studying from 70,204 Zometa users.
Number of Zometa reports submitted per year:
Zometa side effects by time on the drug *:
Zometa side effects by gender *:
Zometa side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Zometa?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on zoledronic acid (the active ingredients of Zometa) and Zometa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Zometa:
- Zometa (70,204 reports)
Common Zometa side effects:
- Aseptic necrosis (the death of bone tissue due to a lack of blood supply): 12,598 reports
- Pain: 11,818 reports
- Stress and anxiety: 8,357 reports
- Fatigue (feeling of tiredness): 7,364 reports
All Zometa side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sumatriptan and Haemorrhoids - 13 seconds ago
- Uroxatral and Cardura drug interaction - 14 seconds ago
- Celebrex and Sleep Disorder - 56 seconds ago
- Percodan and Impaired Healing - 56 seconds ago
- Sodium Bicarbonate and Dermatitis - Atopic - a minute ago
- Sodium Bicarbonate and Eczema - a minute ago
- Albuterol Sulfate and Novalgin drug interaction - a minute ago
- Ofev and Diazepam drug interaction - a minute ago
- Omeprazole Magnesium and Muscle Aches - a minute ago
- Aimovig and Naltrexone Hydrochloride drug interaction - a minute ago